Create Health Limited

Create Health Limited operates in the fertility sector, specializing in mild and natural IVF treatments designed for individual needs, with a focus on enhancing success rates while minimizing emotional and physical burdens. Founded in 2000 and headquartered in London, UK, Create Health Limited is a fertility clinic that provides specialized IVF services. The company underwent a management acquisition from Livingbridge in May 2019, with financial terms undisclosed. It has conducted two deals, with the most recent occurring on May 29, 2019.

The latest funding round was a Growth round, raising GBP 5. 000 mn, bringing the total amount raised to GBP 5. 000 mn. CREATE Fertility specializes in mild and natural IVF treatments, offering services like Mild IVF, Natural Modified IVF, Natural Cycle IVF, ICSI, and IUI.

They cater to women over 40, lesbian couples, and single women, using advanced ultrasound technology to create tailored treatment plans that improve outcomes while lessening traditional IVF's emotional and physical toll. The company's services are accessible across the UK and Denmark, focused on providing effective and personalized reproductive care. In 2022, CREATE Fertility reported revenue of GBP 44,136,718. 60 and an EBITDA of GBP 5,654,673.

90. The revenue model is based on direct-to-consumer transactions, with pricing structures that include packages for multiple IVF cycles and egg sharing options. The firm generates income from consultations and scans integral to the treatment process, combining subscription-like services for ongoing support alongside one-time payments for specific treatments, ensuring a consistent revenue stream. The company aims to develop new fertility treatment products and expand into additional markets following the recent Growth funding round.

CREATE Fertility will leverage the GBP 5. 000 mn raised to support these initiatives and enhance service offerings. Their management's strategic plan includes targeting geographical expansion within Europe, focusing on regions with rising demand for fertility services.